UPCOMING SESSIONS in ET
Thu, Apr 30, 2026
10:00 – 11:00 PM UTC
Stressed Self to Best Self: The Science-Backed System for Sustainable Peak Performance Nick Propper Click To Register
UPCOMING SESSIONS in ET
Thu, Apr 30, 2026 · 10:00 – 11:00 PM UTC
Stressed Self to Best Self: The Science-Backed System for Sustainable Peak Performance
Nick Propper
Click To Register
View all sessions

FDA grants fast track status to Novo Nordisk’s ATTR-CM drug

Published: Apr 27, 2026
Category
News
Source
Investing

DUBLIN - The U.S. Food and Drug Administration has granted Fast Track Designation to coramitug, an investigational antibody for treating ATTR amyloidosis with cardiomyopathy, Prothena Corporation plc (NASDAQ:PRTA) announced today.

News Url
Read More